Caffeic acid attenuates 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced NF-κB and COX-2 expression in mouse skin: Abrogation of oxidative stress, inflammatory responses and proinflammatory cytokine production

Food and Chemical Toxicology

Volumn 50, Issue 2, 2012, Pages 175-183

  Khan, Abdul Quaiyoom ^a   Khan, Rehan ^a   Qamar, Wajhul ^a   Lateef, Abdul ^a   Ali, Farrah ^a   Tahir, Mir ^a   Muneeb U Rehman, ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Caffeic acid; Inflammation; NF B; Oxidative stress; Skin cancer; TPA

Indexed keywords

ACETONE; CAFFEIC ACID; CYCLOOXYGENASE 2; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; INFLAMMATION; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SKIN; TRANSCRIPTION INITIATION; TUMOR PROMOTION; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CAFFEIC ACIDS; CYCLOOXYGENASE 2; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GLUTATHIONE; INFLAMMATION; MICE; NF-KAPPA B; SKIN; TETRADECANOYLPHORBOL ACETATE; XANTHINE OXIDASE;

ANIMALIA;

EID: 84855250857     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.10.043     Document Type: Article

References (59)

1. Afaq F., Saleem M., Krueger C.G., Reed J.D., Mukhtar H. Anthocyanin and hydrolysable tannin-rich pomegranate fruit extract modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in CD-1 mice. International Journal of Cancer 2005, 113:423-433.
2. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
3. Aggarwal B.B., Gehlot P. Inflammation and cancer: how friendly is the relationship for cancer patients?. Curr. Opin. Pharmacol. 2009, 9:351-369.
4. Apel K., Hirt H. Reactive oxygen species: metabolism, oxidative stress and signal transduction. Annu. Rev. Plant Biol. 2004, 55:373-399.
5. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2002, 357:539-545.
6. Ballaz S., Mulshine J.L. The potential contributions of chronic inflammation to lung carcinogenesis. Clin. Lung. Cancer. 2003, 5:46-62.
7. Behrend L., Henderson G., Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 2003, 31:1441-1444.
8. Bickers D.R., Athar M. Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 2006, 126:2565-2575.
9. Bode A.M., Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat. Res. 2004, 555:33-51.
10. Bose J.S., Gangan V., Jain S.K., Manna S.K. Downregulation of inflammatory responses by novel caffeic acid ester derivative by inhibiting NF-kappa B. J. Clin. Immunol. 2009, 29:90-98.
11. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 2000, 59:13-23.
12. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982, 78:206-209.
13. Carlberg I., Mannervik B. Glutathione level in rat brain. J. Biol. Chem. 1975, 250:5475-5480.
14. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim G.J., Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB. J. 2004, 14:1670-1681.
15. Claiborne A. Catalase activity. CRC Handbook of Methods in Oxygen Radical Research 1985, 283-284. CRC, Boca Raton, RA. R.A. Greenwald (Ed.).
16. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 1992, 54:63-128.
17. Farrow B., Evers B.M. Inflammation and the development of pancreatic cancer. Surg. Oncol. 2002, 10:153-169.
18. Gerber M., Astre C., Segala C., Saintot M., Scali J., Simony-Lafontaine J., Grenier J., Pujol H. Tumor progression and oxidant-antioxidant status. Cancer Lett. 1997, 114:211-214.
19. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., Kagnoff M.F., Karin M. IKK links inflammation and cancer and is a possible target for prevention of colitis associated cancer. Cell 2004, 118:285-296.
20. Grunberger D., Banerjee R., Eisinger K., Oltz E.M., Efros L., Caldwell M., Estevez V., Nakanishi K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988, 44:230-232.
21. Ha H.Y., Kim Y., Ryoo Z.Y., Kim T.Y. Inhibition of the TPA induced cutaneous inflammation and hyperplasia by EC-SOD. Biochem. Biophys. Res. Commun. 2006, 348:450-458.
22. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
23. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem. J. 2007, 401:1-11.
24. Johnson A.A., Marchand C., Pommery Y. HIV-1 integrase inhibitors a decade of research and two drugs in clinical trial. Curr. Top. Med. Chem. 2004, 4:1059-1077.
25. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 1974, 11:151-169.
26. Karin M., Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 2000, 12:85-98.
27. Katiyar S.K., Afaq F., Azizuddin K., Mukhtar H. Inhibition of UVBinduced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol. 2001, 176:110-117.
28. Kundu J.K., Shin Y.K., Sung H.K., Surh Y.J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking IκB kinase activity. Carcinogenesis. 2006, 27:1465-1474.
29. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
30. Manna S.K., Mukhopadhyay A., Van N.T., Agarwal B.B. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun Nterminal kinase, and apoptosis. J. Immunol. 1991, 163:6800-6809.
31. Mohan S., Epstein J.B. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral. Oncol. 2003, 39:537-546.
32. Mohandas, M., Marshall, J.J., Duggin, G.G., Horvath, J.S., Tiller, D., 1984. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney.Biochem.Pharmacol.33, 1801-1807.
33. Moon M.K., Lee Y.J., Kim J.S., Kang D.G., Lee H.S. Effect of Caffeic Acid on Tumor Necrosis Factor-Alpha-Induced Vascular Inflammation in Human Umbilical Vein Endothelial Cells. Biol. Pharm. Bull. 2009, 32:1371-1377.
34. Moore R.J., Owens D.M., Stamp G. Mice deficient in tumor necrosis factor-a are resistant to skin. Carcinogenesis. Nat. Med. 1999, 5:828-831.
35. Nakachi K., Imai K., Suga K. Epidemiological evidence for prevention of cancer and cardiovascular disease by drinking green tea. Food Factors for Cancer Prevention 1996, 105-108. Springer, Tokyo. H. Ohigashi, T. Osawa, J. Watanabe, T. Yoshikawa (Eds.).
36. Nakadate, T., 1989.The mechanism of skin tumor promotion caused by phorbol esters: possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems. Jpn. J. Pharmacol. 49, 1-9.
37. Nardini M., DiAquino M., Tomassi G., Gentili V., Di Felice M., Scaccini C. Inhibition of human low density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic. Biol. Med. 1995, 19:541-552.
38. Nardini M., Leonardi F., Scaccini C., Virgili F. Modulation of ceramide-induced NF-kappaB binding activity and apoptotic response by caffeic acid in U937 cells: comparison with other antioxidants. Free Radic. Biol. Med. 2001, 30:722-733.
39. Okutan H., Ozcelikb N., Yilmazb H.R., Uzb E. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin. Biochem. 2005, 38:191-196.
40. Pick A., Keisari Y. Superoxide anion and H2O2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimuli. Cell Immunol. 1981, 59:301-308.
41. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004, 431:461-466.
42. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer. 2004, 4:71-78.
43. Prescott S.M., Fitzpatrick F.A. Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta. 2000, 1470:69-78.
44. Saintot, M., Astre, C., Pujol, H., Gerber, M., 1996.Tumor progression and oxidant-antioxidant status. Carcinogenesis. 17, 1267-1271.
45. Scott K.A., Moore R.J., Arnott C.H. An anti-tumor necrosis factor-a antibody inhibits the development of experimental skin tumors. Mol. Cancer. Ther. 2003, 2:445-451.
46. Seril D.N., Liao J., Yang G.Y., Yang C.S. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003, 24:353-362.
47. Shahidi F., Naczk M. Food Phenolics. Sources, Chemistry, Effects, Applications 1995, Technomic Publishing Company, Inc., Lancaster, PA.
48. Sharma S., Sultana S. Modulatory effect of soy isoflavones on biochemical alterations mediated by TPA in mouse skin model. Food Chem. Toxicol. 2004, 42:1669-1675.
49. Sies H. Oxidative stress: introductory remarks. Oxidative Stress 1985, 1-7. London, Academic Press. H. Sies (Ed.).
50. Stanley P.L., Steiner S., Havens M., Tramposch K.M. Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol. 1991, 4:262-271.
51. Stripe F., Della-Corte E. The regulation of rat liver xanthine oxidase Conversion in vitro of enzyme activity from dehydrogenase (type D) to oxidase (type O). J. Biol. Chem. 1969, 244:3855-3863.
52. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nature Rev. Cancer. 2003, 3:768-780.
53. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480-481:243-268.
54. Wei H., Wei L., Frenkel K., Bowen R., Barnes S. Inhibition of tumour promoter-induced hydrogen peroxide formation in vitro and in viva by genistein. Nutr. Cancer. 1993, 20:1-12.
55. Williams C.S., Mann M., DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene. 1999, 18:7908-7916.
56. Witz G. Active oxygen species as factors in multistage carcinogenesis. Proc. Soc. Exp. Biol. Med. 1991, 198:675-682.
57. Wright J.R., Colby H.D., Miles P.R. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophy. 1981, 206:296-304.
58. Yamada Y., Yasui H., Sakurai H. Suppressive effect of caffeic acid and its derivatives on the generation of UVA-induced reactive oxygen species in the skin of hairless mice and pharmacokinetic analysis on organ distribution of caffeic acid in ddY mice. Photochem. Photobiol. 2006, 82:1668-1676.
59. Yan B., Wang H., Rabbani Z.N., Zhao Y., Li W., Yuan Y., Li F., Dewhirst M.W., Li C.Y. Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res. 2006, 66:11565-11570.